CHI3L1 and Alzheimer disease: Both of them showed similar cohort characteristics, but the study with the highest progression rate (i.e., higher number of MCI patients that developed dementia due to AD), what in itself could be due to the longer follow-up period (32.4 versus 24 months), favored YKL-40 as a predictive biomarker (70).